Mary Kay Fenton, SVP and CFO at ACHILLION PHARMACEUTICALS INC (ACHN), sold 4,250 shares at $7.50 ($32K) on 2011-04-06, disclosed to the SEC on 2011-04-06.
Scheduled sale ($32k) by SVP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.50 | 4,111 | $31K | 96.7% |
| 2 | $7.50 | 139 | $1K | 3.3% |
| Total | $7.50 avg | 4,250 | $32K | 100% |
| Filing → |
| ACHN | SELL | 2015-12-30 | $438K | — | Filing → |
| ACHN | SELL | 2015-01-23 | $210K | — | Filing → |
| ACHN | SELL | 2012-01-11 | $168K | — | Filing → |